Sarah Schmidt Grant
AstraZeneca (Australia)(AU)AstraZeneca (Brazil)(BR)AstraZeneca (Spain)(ES)University of York(GB)Vertex Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Asthma and respiratory diseases, Tuberculosis Research and Epidemiology, Allergic Rhinitis and Sensitization, Antibiotic Resistance in Bacteria, Chronic Obstructive Pulmonary Disease (COPD) Research
Most-Cited Works
- → Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response(2013)366 cited
- → Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals(2012)268 cited
- → Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening(2012)252 cited
- → COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease(2019)177 cited
- → Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32(2013)95 cited
- → Identification of Novel Inhibitors of Nonreplicating Mycobacterium tuberculosis Using a Carbon Starvation Model(2013)86 cited